Analysis of the MMRF CoMMpass dataset identified that 12.3% of newly diagnosed MM patients had a copy number (CN) loss of TRIM33 (Fig. 1A) and demonstrated that patients with TRIM33 loss displayed significantly reduced TRIM33 gene expression (p < 0.0001; Fig. 1B). This evidence concerns the gene TRIM33 and Miyoshi myopathy.